Cholesteryl Ester Transfer Protein ( CETP ) Inhibition Beyond Raising High-Density Lipoprotein Cholesterol Levels Pathways by Which Modulation of CETP Activity May Alter Atherogenesis
暂无分享,去创建一个
J. Kastelein | S. Boekholdt | E. Stroes | J. Kuivenhoven | A. Klerkx | K. Harchaoui | W. A. Steeg | J. Kastelein | E. Stroes | Erik S. G. Stroes | John J. P. Kastelein
[1] L. Jingjing,et al. Antibody against cholesteryl ester transfer protein (CETP) elicited by a recombinant chimeric enzyme vaccine attenuated atherosclerosis in a rabbit model. , 2005, Life sciences.
[2] R. McPherson,et al. Cholesteryl Ester Transfer Protein Directly Mediates Selective Uptake of High Density Lipoprotein Cholesteryl Esters by the Liver , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[3] E. Schaefer,et al. Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux Published, JLR Papers in Press, August 1, 2005. DOI 10.1194/jlr.M500187-JLR200 , 2005, Journal of Lipid Research.
[4] J. Kastelein,et al. Consequences of cholesteryl ester transfer protein inhibition in patients with familial hypoalphalipoproteinemia. , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[5] A. Vaughan,et al. ABCG1 Redistributes Cell Cholesterol to Domains Removable by High Density Lipoprotein but Not by Lipid-depleted Apolipoproteins* , 2005, Journal of Biological Chemistry.
[6] T. V. van Berkel,et al. Scavenger receptor BI and ATP-binding cassette transporter A1 in reverse cholesterol transport and atherosclerosis , 2005, Current opinion in lipidology.
[7] L. Jingjing,et al. Vaccinating Rabbits with a Cholesteryl Ester Transfer Protein (CETP) B-Cell Epitope Carried by Heat Shock Protein-65 (HSP65) for Inducing Anti-CETP Antibodies and Reducing Aortic Lesions In Vivo , 2005, Journal of cardiovascular pharmacology.
[8] P. Scherer,et al. Adipose tissue, inflammation, and cardiovascular disease. , 2005, Circulation research.
[9] M. Trip,et al. Effectiveness of inhibition of cholesteryl ester transfer protein by JTT-705 in combination with pravastatin in type II dyslipidemia. , 2005, The American journal of cardiology.
[10] D. Rader,et al. Effects of Cholesteryl Ester Transfer Protein Inhibition on High-Density Lipoprotein Subspecies, Apolipoprotein A-I Metabolism, and Fecal Sterol Excretion , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[11] P. Barter,et al. Reconstituted High-Density Lipoproteins Inhibit the Acute Pro-Oxidant and Proinflammatory Vascular Changes Induced by a Periarterial Collar in Normocholesterolemic Rabbits , 2005, Circulation.
[12] A. Aljada,et al. Contemporary Reviews in Cardiovascular Medicine Metabolic Syndrome A Comprehensive Perspective Based on Interactions Between Obesity, Diabetes, and Inflammation , 2022 .
[13] D. Shih,et al. Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine. , 2005, Atherosclerosis.
[14] S. Boekholdt,et al. Role of CETP inhibitors in the treatment of dyslipidemia , 2004, Current opinion in lipidology.
[15] J. Kastelein,et al. A review of CETP and its relation to atherosclerosis Published, JLR Papers in Press, September 1, 2004. DOI 10.1194/jlr.R400007-JLR200 , 2004, Journal of Lipid Research.
[16] P. Barter,et al. Antiinflammatory Properties of HDL , 2004 .
[17] K. Saku,et al. Inhibition of Cholesteryl Ester Transfer Protein Activity by JTT-705 Increases Apolipoprotein E–Containing High-Density Lipoprotein and Favorably Affects the Function and Enzyme Composition of High-Density Lipoprotein in Rabbits , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[18] J. Ordóñez‐Llanos,et al. Human Apolipoprotein A-II Enrichment Displaces Paraoxonase From HDL and Impairs Its Antioxidant Properties: A New Mechanism Linking HDL Protein Composition and Antiatherogenic Potential , 2004, Circulation research.
[19] R. Peters,et al. Plasma Levels of Cholesteryl Ester Transfer Protein and the Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women: The Prospective EPIC (European Prospective Investigation into Cancer and nutrition)–Norfolk Population Study , 2004, Circulation.
[20] R. McPherson,et al. Role of cholesteryl ester transfer protein in selective uptake of high density lipoprotein cholesteryl esters by adipocytes Published, JLR Papers in Press, July 1, 2004. DOI 10.1194/jlr.M400051-JLR200 , 2004, Journal of Lipid Research.
[21] Charles C Schwartz,et al. Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans Published, JLR Papers in Press, May 16, 2004. DOI 10.1194/jlr.M300511-JLR200 , 2004, Journal of Lipid Research.
[22] Aldons J Lusis,et al. Thematic review series: The Pathogenesis of Atherosclerosis Published, JLR Papers in Press, April 1, 2004. DOI 10.1194/jlr.R400001-JLR200 The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL , 2004, Journal of Lipid Research.
[23] D. Rader,et al. Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol. , 2004, The New England journal of medicine.
[24] T. Teramoto,et al. Scavenger receptor type BI potentiates reverse cholesterol transport system by removing cholesterol ester from HDL. , 2004, Atherosclerosis.
[25] T. Sand,et al. Raising High-Density Lipoprotein in Humans Through Inhibition of Cholesteryl Ester Transfer Protein: An Initial Multidose Study of Torcetrapib , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[26] E. Schaefer,et al. Apolipoprotein composition of HDL in cholesteryl ester transfer protein deficiency Published, JLR Papers in Press, December 1, 2003. DOI 10.1194/jlr.M300198-JLR200 , 2004, Journal of Lipid Research.
[27] E. D. de Faria,et al. Antioxidative Activity of HDL Particle Subspecies Is Impaired in Hyperalphalipoproteinemia: Relevance of Enzymatic and Physicochemical Properties , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[28] D. Rader,et al. In vivo modulation of HDL phospholipid has opposing effects on SR-BI- and ABCA1-mediated cholesterol efflux Published, JLR Papers in Press, November 1, 2003. DOI 10.1194/jlr.M300231-JLR200 , 2004, Journal of Lipid Research.
[29] B. Zhang,et al. Inhibition of cholesteryl ester transfer protein increases serum apolipoprotein (apo) A-I levels by increasing the synthesis of apo A-I in rabbits. , 2004, Atherosclerosis.
[30] F. Kuipers,et al. The ins and outs of reverse cholesterol transport , 2004, Annals of medicine.
[31] M. Togo,et al. Modulation of HDL metabolism by probucol in complete cholesteryl ester transfer protein deficiency. , 2003, Atherosclerosis.
[32] A. Rigotti,et al. Influence of the HDL Receptor SR-BI on Lipoprotein Metabolism and Atherosclerosis , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[33] A. Kontush,et al. Small, Dense HDL Particles Exert Potent Protection of Atherogenic LDL Against Oxidative Stress , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[34] M. Reilly,et al. Overexpression of Apolipoprotein A-I Promotes Reverse Transport of Cholesterol From Macrophages to Feces In Vivo , 2003, Circulation.
[35] E. Bruckert,et al. Action of ciprofibrate in type IIb hyperlipoproteinemia: modulation of the atherogenic lipoprotein phenotype and stimulation of high-density lipoprotein-mediated cellular cholesterol efflux. , 2003, The Journal of clinical endocrinology and metabolism.
[36] P. McElduff,et al. Low Paraoxonase Activity Predicts Coronary Events in the Caerphilly Prospective Study , 2003, Circulation.
[37] H. Mabuchi,et al. Dual effects on HDL metabolism by cholesteryl ester transfer protein inhibition in HepG2 cells. , 2003, American journal of physiology. Endocrinology and metabolism.
[38] Yeong-Ok Song,et al. Red pepper attenuates cholesteryl ester transfer protein activity and atherosclerosis in cholesterol-fed rabbits. , 2003, Clinica chimica acta; international journal of clinical chemistry.
[39] G. Anantharamaiah,et al. A quantitative analysis of apolipoprotein binding to SR-BI: multiple binding sites for lipid-free and lipid-associated apolipoproteins. , 2003, Journal of lipid research.
[40] P. Yancey,et al. Importance of different pathways of cellular cholesterol efflux. , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[41] S. Going,et al. Cholesteryl ester transfer protein and lecithin:cholesterol acyltransferase activities in hispanic and anglo postmenopausal women: associations with total and regional body fat. , 2003, Metabolism: clinical and experimental.
[42] D. Rader,et al. Cholesteryl Ester Transfer Protein: A Novel Target for Raising HDL and Inhibiting Atherosclerosis , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[43] C. Lutton,et al. Postprandial variations in the cholesteryl ester transfer protein activity, phospholipid transfer protein activity and plasma cholesterol efflux capacity in normolipidemic men. , 2003, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[44] A. Tselepis,et al. Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase. , 2002, Atherosclerosis. Supplements.
[45] M. Eriksson,et al. Reverse cholesterol transport in man: promotion of fecal steroid excretion by infusion of reconstituted HDL. , 2002, Atherosclerosis. Supplements.
[46] P. Barter,et al. Hugh sinclair lecture: the regulation and remodelling of HDL by plasma factors. , 2002, Atherosclerosis. Supplements.
[47] G. Siest,et al. Lipid Free Apolipoprotein E Binds to the Class B Type I Scavenger Receptor I (SR-BI) and Enhances Cholesteryl Ester Uptake from Lipoproteins* , 2002, The Journal of Biological Chemistry.
[48] E. Favari,et al. Cellular cholesterol flux studies: methodological considerations. , 2002, Atherosclerosis.
[49] A. Zwinderman,et al. Efficacy and Safety of a Novel Cholesteryl Ester Transfer Protein Inhibitor, JTT-705, in Humans: A Randomized Phase II Dose-Response Study , 2002, Circulation.
[50] H. Okamoto,et al. Effect of HDL, from Japanese white rabbit administered a new cholesteryl ester transfer protein inhibitor JTT-705, on cholesteryl ester accumulation induced by acetylated low density lipoprotein in J774 macrophage. , 2002, Atherosclerosis.
[51] S. Yamashita,et al. Expression of cholesteryl ester transfer protein in human atherosclerotic lesions and its implication in reverse cholesterol transport. , 2001, Atherosclerosis.
[52] T. Miida,et al. LR11, a Mosaic LDL Receptor Family Member, Mediates the Uptake of ApoE-Rich Lipoproteins In Vitro , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[53] A. Simon,et al. Analysis of the relationship between triglyceridemia and HDL-phospholipid concentrations: consequences on the efflux capacity of serum in the Fu5AH system. , 2001, Atherosclerosis.
[54] L. Izem,et al. Cholesteryl Ester Transfer Protein Biosynthesis and Cellular Cholesterol Homeostasis Are Tightly Interconnected* , 2001, The Journal of Biological Chemistry.
[55] R. S. Meidell,et al. Effect of Up-regulating Individual Steps in the Reverse Cholesterol Transport Pathway on Reverse Cholesterol Transport in Normolipidemic Mice* , 2001, The Journal of Biological Chemistry.
[56] Y. Akasaka,et al. The distribution and production of cholesteryl ester transfer protein in the human aortic wall. , 2001, Atherosclerosis.
[57] F. Kuipers,et al. Hepatobiliary cholesterol transport is not impaired in Abca1-null mice lacking HDL. , 2001, The Journal of clinical investigation.
[58] Admar Costa de Oliveira,et al. Oxidation of LDL enhances the cholesteryl ester transfer protein (CETP)-mediated cholesteryl ester transfer rate to HDL, bringing on a diminished net transfer of cholesteryl ester from HDL to oxidized LDL. , 2001, Clinica chimica acta; international journal of clinical chemistry.
[59] S. Yamashita,et al. Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein. , 2000, Biochimica et biophysica acta.
[60] A. Tall,et al. Specific Binding of ApoA-I, Enhanced Cholesterol Efflux, and Altered Plasma Membrane Morphology in Cells Expressing ABC1* , 2000, The Journal of Biological Chemistry.
[61] A. Callow,et al. Vaccine-Induced Antibodies Inhibit CETP Activity In Vivo and Reduce Aortic Lesions in a Rabbit Model of Atherosclerosis , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[62] S. Reddy,et al. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1. , 2000, Journal of lipid research.
[63] K. Wakitani,et al. A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits , 2000, Nature.
[64] A. Tedgui,et al. CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors. , 2000, Circulation.
[65] R. F. Hoyt,et al. Cholesteryl Ester Transfer Protein Corrects Dysfunctional High Density Lipoproteins and Reduces Aortic Atherosclerosis in Lecithin Cholesterol Acyltransferase Transgenic Mice* , 1999, The Journal of Biological Chemistry.
[66] M. Eriksson,et al. Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I. Potential reverse cholesterol transport in humans. , 1999, Circulation.
[67] K. Matsumoto,et al. Expression of human scavenger receptor class B type I in cultured human monocyte-derived macrophages and atherosclerotic lesions. , 1999, Circulation research.
[68] A. Tall,et al. Remodeling of HDL by CETP in vivo and by CETP and hepatic lipase in vitro results in enhanced uptake of HDL CE by cells expressing scavenger receptor B-I. , 1999, Journal of lipid research.
[69] M C Phillips,et al. Cell cholesterol efflux: integration of old and new observations provides new insights. , 1999, Journal of lipid research.
[70] J. Segrest,et al. Potencies of lipoproteins in fasting and postprandial plasma to accept additional cholesterol molecules released from cell membranes. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[71] H. Hobbs,et al. Kinetic characteristics and regulation of HDL cholesteryl ester and apolipoprotein transport in the apoA-I-/- mouse. , 1998, Journal of lipid research.
[72] B. La Du,et al. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. , 1998, The Journal of clinical investigation.
[73] M. Kamada,et al. Effect of Antisense Oligonucleotides against Cholesteryl Ester Transfer Protein on the Development of Atherosclerosis in Cholesterol-fed Rabbits* , 1998, The Journal of Biological Chemistry.
[74] C. Packard,et al. Lipoprotein heterogeneity and apolipoprotein B metabolism. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[75] D. Gómez-Coronado,et al. CLA-1 is an 85-kD plasma membrane glycoprotein that acts as a high-affinity receptor for both native (HDL, LDL, and VLDL) and modified (OxLDL and AcLDL) lipoproteins. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[76] R. McPherson,et al. Cholesteryl Ester Transfer Protein Mediates Selective Uptake of High Density Lipoprotein Cholesteryl Esters by Human Adipose Tissue* , 1997, The Journal of Biological Chemistry.
[77] Yong Ji,et al. Scavenger Receptor BI Promotes High Density Lipoprotein-mediated Cellular Cholesterol Efflux* , 1997, The Journal of Biological Chemistry.
[78] P. Heikkilä,et al. Ribonucleic acid expression of the CLA-1 gene, a human homolog to mouse high density lipoprotein receptor SR-BI, in human adrenal tumors and cultured adrenal cells. , 1997, The Journal of clinical endocrinology and metabolism.
[79] A. Lusis,et al. Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles. , 1997, The Journal of clinical investigation.
[80] Ming Liu,et al. Novel Function of Lecithin-Cholesterol Acyltransferase , 1997, The Journal of Biological Chemistry.
[81] L. Woollett,et al. Kinetic parameters for high density lipoprotein apoprotein AI and cholesteryl ester transport in the hamster. , 1997, The Journal of clinical investigation.
[82] S. Robins,et al. High density lipoproteins, but not other lipoproteins, provide a vehicle for sterol transport to bile. , 1997, The Journal of clinical investigation.
[83] O. Francone,et al. Increased prebeta-HDL levels, cholesterol efflux, and LCAT-mediated esterification in mice expressing the human cholesteryl ester transfer protein (CETP) and human apolipoprotein A-I (apoA-I) transgenes. , 1996, Journal of lipid research.
[84] A. Tall,et al. Cholesterol efflux potential of sera from mice expressing human cholesteryl ester transfer protein and/or human apolipoprotein AI. , 1995, The Journal of clinical investigation.
[85] D. Rader,et al. Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency. , 1995, The Journal of clinical investigation.
[86] S. Yamashita,et al. Decreased affinity of low density lipoprotein (LDL) particles for LDL receptors in patients with cholesteryl ester transfer protein deficiency , 1995, European journal of clinical investigation.
[87] S. Horiuchi,et al. Structural and functional differences of subspecies of apoA-I-containing lipoprotein in patients with plasma cholesteryl ester transfer protein deficiency. , 1995, Journal of lipid research.
[88] S. Yamashita,et al. Large and cholesteryl ester-rich high-density lipoproteins in cholesteryl ester transfer protein (CETP) deficiency can not protect macrophages from cholesterol accumulation induced by acetylated low-density lipoproteins. , 1994, Journal of biochemistry.
[89] P. Giral,et al. A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transfer. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[90] S. Yamashita,et al. Increased plasma cholesteryl ester transfer protein in obese subjects. A possible mechanism for the reduction of serum HDL cholesterol levels in obesity. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[91] A. Tall,et al. Down-regulation of mRNA for the low density lipoprotein receptor in transgenic mice containing the gene for human cholesteryl ester transfer protein. Mechanism to explain accumulation of lipoprotein B particles. , 1993, The Journal of biological chemistry.
[92] D. Rader,et al. Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency. , 1993, The Journal of clinical investigation.
[93] A. Tall,et al. Plasma cholesteryl ester transfer protein. , 1993, Journal of lipid research.
[94] D. Knook,et al. Selective uptake of cholesteryl esters from apolipoprotein-E-free high-density lipoproteins by rat parenchymal cells in vivo is efficiently coupled to bile acid synthesis. , 1991, The Biochemical journal.
[95] P. Gambert,et al. Effect of rat plasma high density lipoprotein with or without apolipoprotein E on the cholesterol uptake and on the induction of the corticosteroid biosynthetic pathway in newborn rat adrenocortical cell cultures. , 1991, Biochimica et biophysica acta.
[96] A. Tall,et al. Mammalian adipose tissue and muscle are major sources of lipid transfer protein mRNA. , 1991, The Journal of biological chemistry.
[97] S. Yamashita,et al. Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency. , 1990, The Journal of clinical investigation.
[98] F. Rinninger,et al. Mechanism of the cholesteryl ester transfer protein-mediated uptake of high density lipoprotein cholesteryl esters by Hep G2 cells. , 1989, The Journal of biological chemistry.
[99] B. Paulweber,et al. Lipoprotein binding to cultured human hepatoma cells. , 1987, The Journal of clinical investigation.
[100] A. Tall,et al. Human plasma cholesteryl ester transfer protein enhances the transfer of cholesteryl ester from high density lipoproteins into cultured HepG2 cells. , 1987, The Journal of biological chemistry.
[101] B. R. Krause,et al. Adipose tissue and cholesterol metabolism. , 1984, Journal of lipid research.
[102] G. Chisolm,et al. LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. , 1979, Atherosclerosis.
[103] J. Glomset,et al. The plasma lecithins:cholesterol acyltransferase reaction. , 1968, Journal of lipid research.
[104] N. Hyka,et al. Articles on similar topics can be found in the following Blood collections , 2013 .
[105] D. Moller,et al. Metabolic syndrome: a clinical and molecular perspective. , 2005, Annual review of medicine.
[106] G. Franceschini,et al. Depletion of pre-beta-high density lipoprotein by human chymase impairs ATP-binding cassette transporter A1- but not scavenger receptor class B type I-mediated lipid efflux to high density lipoprotein. , 2004, The Journal of biological chemistry.
[107] M. Guerin,et al. Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemia. , 2004, Pharmacology & therapeutics.
[108] M. Gidlund,et al. Cholesteryl ester transfer protein expression attenuates atherosclerosis in ovariectomized mice , 2002 .
[109] M. Farnier,et al. Action of atorvastatin in combined hyperlipidemia : preferential reduction of cholesteryl ester transfer from HDL to VLDL1 particles. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[110] G. Fonarow,et al. formation of , 2022 .
[111] M. Kamada,et al. Low density lipoproteins develop resistance to oxidative modification due to inhibition of cholesteryl ester transfer protein by a monoclonal antibody. , 2000, Journal of lipid research.
[112] W. Beltz,et al. Evaluation of pathways for the cellular uptake of high density lipoprotein cholesterol esters in rabbits. , 1991, The Journal of clinical investigation.
[113] SR-BI- and ABCA1-mediated cholesterol efflux to serum from patients with Alagille syndrome , 2022 .